Extracted from this filing and checked against the source text.
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Harmony Biosciences Holdings, Inc. entered into New Credit Agreement with JPMorgan Chase Bank, N.A., as administrative agent, and certain lenders valued at $185.0 million (effective 2023-07-26).
- Action
- entry
- Agreement
- credit facility
- Counterparty
- JPMorgan Chase Bank, N.A., as administrative agent, and certain lenders
- Value
- $185.0 million
- Effective
- 2023-07-26
Exact text from the filing
On July 26, 2023 (the “Closing Date”), Harmony Biosciences Holdings, Inc. (the “Company”) entered into a Credit Agreement (the “New Credit Agreement”) with JPMorgan Chase Bank, N.A., as administrative agent, and certain lenders. The New Credit Agreement provides for a five-year senior secured term loan (the “Loan”) in an aggregate principal amount of $185.0 million.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Harmony Biosciences Holdings, Inc. terminated Blackstone Loan with Blackstone Alternative Credit Advisors LP and the other lenders party thereto from time to time and Wilmington Trust, National Association, as administrative agent valued at $200 million (effective 2023-07-26).
- Action
- termination
- Agreement
- credit facility
- Counterparty
- Blackstone Alternative Credit Advisors LP and the other lenders party thereto from time to time and Wilmington Trust, National Association, as administrative agent
- Value
- $200 million
- Effective
- 2023-07-26
Exact text from the filing
On July 26, 2023, upon entry into the New Credit Agreement described in Item 1.01 above, together with cash on hand, the Blackstone Loan was repaid in full, and all commitments thereunder were terminated.
View on SEC.gov